Central Venous Catheters Market Size, Share, Growth, Trends, and Forecast 2030

Industry Prospective:

The global Central Venous Catheters market size was worth around USD 1,848.50 billion in 2021 and is estimated to grow to about USD 2607.32528 billion by 2028, with a compound annual growth rate (CAGR) of approximately 5.90 percent over the forecast period. The report analyzes the Central Venous Catheters market’s drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the Central Venous Catheters market.

Request Free Sample

Central Venous Catheters Market: Overview

In Central Venous Catheters Market Report, Central venous catheters, also known as central lines, central catheters, or central venous access devices, play a critical role in the treatment of a wide range of medical disorders. Catheters are small, flexible tubes that are placed into a big vein near a patient's heart. The other end of the gadget makes it easier to provide medications, fluids, and other substances.

In comparison to peripheral intravenous lines, central venous catheters are longer and larger in size. People who are undergoing cancer therapy may be prescribed these devices. Patients with difficult-to-find, frail, or damaged veins, as well as those whose arms are unsuitable for intravenous line use, might consider central venous catheters. The market for Central Venous Catheters is predicted to grow as major companies develop production facilities and participate in joint ventures to manufacture these devices.

The market is being driven by rising hospitalization rates and increased catheter adoption rates. Socioeconomic factors, such as the growing geriatric population and rising incidences of various chronic diseases, including malignant cancer, are also driving the market growth. These factors are driving the demand for antimicrobial-coated catheters. The increasing number of product developments is another important growth factor.

The increased development of tip location devices that enable precise placement or positioning of the central venous catheter has fueled rapid growth in the global central venous catheter market. The reimbursement status of central venous catheters is determined by the patient's age, product category, indication, and insertion process. Manufacturers of central venous catheters are putting more money into improving product quality and design in order to reduce hazards and ensure patient safety.

Request Free Sample

COVID-19 Impact:

During the continuing COVID-19 pandemic, the healthcare sector has encountered a number of obstacles, ranging from an increase in COVID-positive cases to increased demand for a variety of additional diagnostic options.

Furthermore, lockdown measures and transportation limitations in various countries throughout the world have had a significant influence on the healthcare sector's operations. As a result of these occurrences, a number of significant smart card manufacturers in the healthcare market have released a number of new goods and services to ensure that the healthcare system runs smoothly.

Central Venous Catheters Market: Growth Drivers

Drivers:

The increasing number of cardiovascular and cancer patients, the aging population, and people suffering from a variety of chronic conditions are the primary growth drivers for the Central Venous Catheters Market.

Restraint:

In the projected period, risks such as central vein damage, pulmonary difficulties, cardiac complications, device malfunction, catheter-related bloodstream infection, and increased usage of other vascular access devices will restrain the market.

Challenges:

Patients on maintenance hemodialysis still rely on central venous catheters for access. For all stakeholders involved in CVCs, there are numerous critical and developing clinical and regulatory considerations. To help promote better output results for patients getting maintenance hemodialysis, innovation, transparency, and a thorough regulatory examination of these devices are required. A committee comprised of industry leaders and members from the US Food and Drug Administration was formed to identify the primary design considerations, clinical and regulatory issues, and clinical and regulatory challenges of CVC for hemodialysis.

Global Central Venous Catheters Market: Segmentation

The global Central Venous Catheters market is segregated based on product type, Property, Design, Composition, and End-use.

Based on Property, the market is divided into Antimicrobial Catheters and Non-Antimicrobial Catheters. Antimicrobial central venous catheters account for the largest share in the market. Antimicrobial agents have been impregnated into these catheters. An antiseptic surface (silver sulfadiazine/chlorhexidine), an antibiotic coating, or a silver-impregnated collagen cuff can all be used. Antimicrobial-coated catheters have gained popularity in recent years as a result of a greater focus on preventing Healthcare-Associated Infections (HAIs), as the coated devices can provide additional protection against bloodstream infections in situations where the device is in prolonged contact with body fluids and tissue.

Based on composition, the market is segmented into Polyurethane, Polyurethane / Poly Carbonate, and Silicone Silicon catheters, which make up the majority of soft central venous catheters, and accounted for the largest share of the market growth in 2021. Silicone catheters are preferred for long-term, tunnelled CVCs due to their softness and flexibility. These, on the other hand, are sometimes utilized for temporary or short-term objectives. Silicone CVCs have a high friction coefficient.

Report Scope:

Regional Landscape

North America is the main market for central venous catheters, accounting for a large portion of the market's revenue growth. The reasons for this are enhanced medical facilities and well-developed healthcare infrastructure, as well as rising cancer, cardiovascular, and end-stage renal disease rates and an aging population.

Over the projection period, the market in the Asia Pacific is predicted to develop at a faster rate due to an expanding patient pool, rising government initiatives to improve healthcare facilities and rising disposable income in various countries in the area.

Competitive Landscape

Some of the main competitors dominating the global Central Venous Catheters market include – Braun Melsungen AG, Becton, Dickinson and Company, ICU Medical Inc., Poly Medicure Ltd., Teleflex Incorporated Lepu Medical Technology Co., Ltd., Cook Group, Insung Medical, VOGT Medical, ZOLL Medical Corporation, EETA Surgical, QMD, Kimal and Analyst Views

Global Central Venous Catheters market is segmented as follows:

By Product Type

• Tunnelled Catheters
• Non-Tunnelled Catheters

By Property

• Antimicrobial Catheters
• Non Antimicrobial Catheters

By Design

• Single Lumen
• Double Lumen
• Multi Lumen

By Composition

• Polyurethane
• Polyurethane / Poly Carbonate
• Silicone

By End Use

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics & Others

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France 
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa